Fluetonitazepyne

Last updated

Fluetonitazepyne
Fluetonitazepyne structure.png
Identifiers
  • 2-[[4-(2-fluoroethoxy)phenyl]methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole
PubChem CID
Chemical and physical data
Formula C22H25FN4O3
Molar mass 412.465 g·mol−1
3D model (JSmol)
  • C1CCN(C1)CCN2C3=C(C=C(C=C3)[N+](=O)[O-])N=C2CC4=CC=C(C=C4)OCCF
  • InChI=1S/C22H25FN4O3/c23-9-14-30-19-6-3-17(4-7-19)15-22-24-20-16-18(27(28)29)5-8-21(20)26(22)13-12-25-10-1-2-11-25/h3-8,16H,1-2,9-15H2
  • Key:TYLHUWCBBIQCEH-UHFFFAOYSA-N

Fluetonitazepyne (F-etonitazepyne, 2-fluoroetonitazepyne) is a benzimidazole derivative which is an opioid designer drug. It was first identified in Italy in July 2024, [1] and subsequently isolated in Finland in early 2025 from the body fluids of five people who had died from opioid overdose. [2]

See also

References

  1. ↑ "Fluetonitazene" (PDF). EU Early Warning System Formal Notification. European Union Drugs Agency (EUDA). 14 May 2024.
  2. ↑ Kriikku P, Pelander A, Jylhä A, Ojanperä I (2025). "Post-Mortem Identification and Toxicological Findings of Fluetonitazepyne and Isotonitazepyne". Drug Testing and Analysis dta.3928. doi:10.1002/dta.3928.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.